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Histogram that quantifies in 1D the orientation and position 
of an OAR to the PTV[3]; to more complex such a non-rigid 
registration based [4]. Also the strategies to predict the dose 
based on the selected patients vary in complexity: from the 
lowest achievable dose among all more “difficult” patients 
[5], to principal component analyses that combine achieved 
doses of multiple patients and organs to make the predictions 
[6]. Different models have been successfully applied for 
prostate, head-and-neck, pancreatic and lung cancer patients 
[2, 4, 7, 8]. 
 
Evaluation of the performance of different treatment 
planning QA models 
An important challenge for the development of treatment 
planning QA models is that the plans to train and validate the 
models are often generated with the same trial and error 
treatment planning process, as where the treatment planning 
QA models are intended for in the first place. Suboptimal 
plans used for training and validation could lead to 
suboptimal models, a bias in the evaluation of the prediction 
accuracy, suboptimal action levels and difficulties to 
compare different models that were trained on different 
patients cohorts. Therefore, recently our group has 
generated a dataset of 115 Pareto optimal IMRT treatment 
plans for prostate cancer patients that were planned fully 
automatically with consistent prioritization between PTV 
coverage, sparing of organs at risk, and conformality (see 
abstract Wang, Breedveld, Heijmen, Petit). This dataset has 
been made publicly available and can be used for objective 
validation of existing and development of new treatment 
planning QA models. 
 
Conclusion 
There is a need for treatment planning QA models to assess 
whether a generated treatment plan is indeed optimal for 
the patient specific anatomy. Different models have been 
proposed for this purpose that vary in complexity. There are 
currently some challenges for clinical implementation, but 
these are likely to be solved in the near future.  
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Purpose 
The purpose of thispresentation is to show the capabilities of 
treatment unit log files for QA, aswell as their limitations. To 
this aim, the implementation of a QA Programbased on 
Varian dynalogs is presented together with the results 
obtained. Thepossibility of replacing phantom-based 
pretreatment QA by log file analysiswill also be discussed 
during the presentation. 
QA Program 
The QA Program wasdeveloped with in-house software, in 
particular with Java (dynalog analysis), MATLAB® (fluence 
calculation andcomparisons) and MySQL (data storage and 
reports). Three Varian linacs wereevaluated and >60,000 
dynalogs were analyzed, corresponding to both slidingwindow 
and VMAT techniques. 
As part of this QA Program,all IMRT beam deliveries were 
verified by the following tests: 
· Analysis of the RMS (Root Mean Square) values of leaf 
positionalerrors. RMS values from different deliveries of the 
same beams were verystable, with differences between 
different fractions <0.05mm in over 99.9%of the cases. This 
shows that the MLC positioning is extremely reproducible. 
· Analysis of the maximum leaf positioning deviations. 
Maximumdeviations were typically within 1-1.5mm and 
depended mainly on the maximumleaf speed. 
· Incidence of beam hold-offs and beam interruptions. The 
meanincidence was 1 hold-off for every 3 dynamic beams 
deliveries and <1% beamswith interruptions (related to any 
kind of interlock). 
· Comparison of the planned fluence and the actual 
fluencecomputed from dynalogs. Excellent agreement was 
obtained, with passingrate>98% for gamma 1%/1mm in 
practically all cases (>99.9% of the beams). 
Limitations and validation of dynalogs 
In general, the accuracy oflog files is unclear, especially if 
they come from non-independent systems.Information in 
Varian dynalogs comes from the MLC controller, that is, from 
thesame motor encoders that drive the MLC. For this reason, 
dynalog files will NOTdetect errors due to MLC calibration 
parameters (dosimetric leaf gap, offset,skew), motor count 
losses or backlash. Indeed, Varian dynalogs must becarefully 
validated by experimentally checking the accuracy of MLC 
positioning,preferably at different gantry angles and at the 
end of the treatment day (dueto the cumulative effect of 
motor count losses since MLC initialization). 
Another limitation ofdynalogs is that several aspects of 
treatment delivery are not recorded in logfiles (beam 
symmetry, homogeneity, energy…). However, these other 
aspects arenot specific to IMRT treatments and should be 
verified as part of the routinestandard QA Program. 
Conclusions 
Logfile analysis allows exhaustive monitoring of MLC 
performance and other machineparameters. 
Implementing a QA Programbased on dynalogs makes it 
possible to control data transfer integrity and ALLtreatment 
deliveries (the entire course of treatment). 
Theefficiency of QA can be increased with a fully automated 
and integrated QAprogram based on log file analysis. 
Commercial software is available which alsoincorporates 
independent dose calculations. 
Log file analysis providesa useful complement to a general 
‘conventional’ QA program. However, validationof log files 
against measurements isneeded. In Varian environments, 
daily experimental verification of theMLC positioning, 
preferably at different gantry angles and at the end of 
thetreatment day, is strongly recommended. 
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Over the last years, the efficacy of radiation oncology 
treatmentsimproved dramatically. However, due to the 
increase in technical complexity anddose escalation, the risk 
of secondary effects also rises. In vivo dosimetry(IVD) is now 
widely recommended to avoid major treatment errors and is 
evenmandatory in several countries. 
In this perspective, transit dosimetry using amorphous 
siliconElectronic Portal Imaging Devices (EPID) appears to be 
an interesting solutionfor several practical reasons (easy to 
use, no additional time, no perturbationin the beam, 2D 
detectors, complex techniques possible, numerical data, 
etc…). Forall these reasons, daily controls for every patient 
becomes realistic. However,with constrained resources 
(staffing, time, etc…), this will become feasible in the clinic 
by means of automated systems.Medical physics teams will 
then be able to set and managea permanent survey system: 
· To verify the actual radiation dosedelivered to the patient 
during the procedure 
· Detect errors before it is too late 
